相关实验视频

Updated: Jan 7, 2026

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.8K

甲基连接器和受体介导 博尔特佐米布的局部特异性输送用于对抗非小细胞肺癌

Mohan Indhu1, Valappil Sisila2, Devandran Jayasurya3

  • 1Department of Biochemistry and Biotechnology, Council of Scientific and Industrial Research (CSIR) - Central Leather Research Institute, Chennai, Tamil Nadu - 600020, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India.

The Journal of biological chemistry
|December 24, 2025
PubMed
概括

研究人员开发了一种新的方法,通过使用ACE2受体向,专门向非小细胞肺癌 (NSCLC) 输送博特佐米布 (BTZ). 这种方法提高了药物输送,并减少了临床前模型中的毒性.

关键词:
3,4-二基烯-L-氨酸的3,4-二基烯-L-氨酸.受体结合域是受体的结合域.ангиотензин转化酶-2 的作用.生物对等的结合关系.博尔特佐米布 (Bortezomib) 是一种药物.甲基乙酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸甲酸.特定地点的交付服务.

更多相关视频

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

8.0K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.1K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.8K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.3K